BioLargo to Present at Virtual Investor Summit on March 25, 2021 at 1:30 PM ET

CEO Dennis Calvert to Highlight the Company’s Sustainable Technologies and Commercialization Traction

Westminster, CA – March 17, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and a full-service environmental engineering company, today announced that its CEO, Dennis Calvert, will present live to an online audience at the Q1 Virtual Investor Summit being held March 23-25, 2021 by the Investor Summit Group. The fully immersive conference features live presentations from CEOs of small- and mid-cap companies across multiple industries and one-on-one meetings with qualified investors. 

 

BioLargo Presentation at the Q1 Virtual Investor Summit 

·         DATE: Thursday, March 25, 2021 

·         TIME: 1:30 PM Eastern Time  

·         REGISTRATION: https://investorsummitgroup.com/register/  

 

Calvert will provide an overview of the company’s cutting-edge cleantech technologies and the successes the company has had in deploying them around the country to solve environmental challenges.

  

The Virtual Investor Summit is an exclusive, independent investor conference dedicated to connecting small-cap and microcap companies with qualified investors. The Q1 Virtual Investor Summit will feature approximately 100 companies and over 300 institutional, family office, high net worth investors and registered investment advisers. To register for the event, visit www.investorsummitgroup.com  

 

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BLGO holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BLGO has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

 

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act – caution regarding forward looking statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.